Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

The efficacy of retreatment with immunomodulatory drugs (IMiDs) among patients with multiple myeloma who received this class of drugs for initial therapy is unknown. We studied 140 patients who received either thalidomide-dexamethasone (81; 58%) or lenalidomide-dexamethasone (59; 42%) as first-line...

Full description

Saved in:
Bibliographic Details
Main Authors: Madan, Sumit, Lacy, Martha Q., Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis, Hayman, Suzanne R., Detweiler-Short, Kristen, Dingli, David, Zeldenrust, Steven, Lust, John, Greipp, Philip R., Rajkumar, S. Vincent, Kumar, Shaji
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2011
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3158710/
https://ncbi.nlm.nih.gov/pubmed/21673347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-350009
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items